TreeWAS – Variant ID: rs2833991

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F10.0 Acute intoxication	0.000	0.991	0.009
F10.1 Harmful use	0.000	0.992	0.008
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.993	0.007
N39.3 Stress incontinence	0.007	0.993	0.000
F10.4 Withdrawal state with delirium	0.000	0.994	0.006
F10.2 Dependence syndrome	0.000	0.994	0.006
F10.9 Unspecified mental and behavioural disorder	0.000	0.994	0.005
F10.8 Other mental and behavioural disorders	0.000	0.994	0.005
F10.7 Residual and late-onset psychotic disorder	0.000	0.994	0.005
F10.6 Amnesic syndrome	0.000	0.994	0.005
F10.5 Psychotic disorder	0.000	0.994	0.005
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.000	0.996	0.004
F10.3 Withdrawal state	0.000	0.996	0.004
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.996	0.004
F17 Mental and behavioural disorders due to use of tobacco	0.000	0.997	0.003
J47 Bronchiectasis	0.000	0.997	0.003
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.997	0.003
K85.9 Acute pancreatitis, unspecified	0.003	0.997	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.000	0.997	0.003
F18 Mental and behavioural disorders due to use of volatile solvents	0.000	0.997	0.003
F16 Mental and behavioural disorders due to use of hallucinogens	0.000	0.997	0.003
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.000	0.997	0.003
F14 Mental and behavioural disorders due to use of cocaine	0.000	0.997	0.003
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.000	0.997	0.003
F12 Mental and behavioural disorders due to use of cannabinoids	0.000	0.997	0.003
F11 Mental and behavioural disorders due to use of opioids	0.000	0.997	0.003
L40.9 Psoriasis, unspecified	0.003	0.997	0.000
A04.5 Campylobacter enteritis	0.003	0.997	0.000
A04 Other bacterial intestinal infections	0.003	0.997	0.000
F32.9 Depressive episode, unspecified	0.000	0.997	0.003
A09.9 Gastroenteritis and colitis of unspecified origin	0.003	0.997	0.000
L40.5 Arthropathic psoriasis	0.003	0.997	0.000
L40 Psoriasis	0.003	0.997	0.000
A04.8 Other specified bacterial intestinal infections	0.003	0.997	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.997	0.003
K85.1 Biliary acute pancreatitis	0.003	0.997	0.000
F17.1 Harmful use	0.000	0.997	0.003
F32 Depressive episode	0.000	0.997	0.003
L40.0 Psoriasis vulgaris	0.003	0.997	0.000
K85 Acute pancreatitis	0.003	0.997	0.000
F17.9 Unspecified mental and behavioural disorder	0.000	0.997	0.003
F17.8 Other mental and behavioural disorders	0.000	0.997	0.003
F17.7 Residual and late-onset psychotic disorder	0.000	0.997	0.003
F17.6 Amnesic syndrome	0.000	0.997	0.003
F17.5 Psychotic disorder	0.000	0.997	0.003
F17.4 Withdrawal state with delirium	0.000	0.997	0.003
F17.3 Withdrawal state	0.000	0.997	0.003
F17.0 Acute intoxication	0.000	0.997	0.003
Z36.8 Other antenatal screening	0.000	0.997	0.003
F17.2 Dependence syndrome	0.000	0.997	0.003
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.997	0.003
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.997	0.003
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.003	0.997	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.997	0.003
F11.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F11.8 Other mental and behavioural disorders	0.000	0.997	0.002
F11.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F11.6 Amnesic syndrome	0.000	0.997	0.002
F11.5 Psychotic disorder	0.000	0.997	0.002
F11.4 Withdrawal state with delirium	0.000	0.997	0.002
F11.3 Withdrawal state	0.000	0.997	0.002
F11.2 Dependence syndrome	0.000	0.997	0.002
F11.1 Harmful use	0.000	0.997	0.002
F11.0 Acute intoxication	0.000	0.997	0.002
F12.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F12.8 Other mental and behavioural disorders	0.000	0.997	0.002
F12.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F12.6 Amnesic syndrome	0.000	0.997	0.002
F12.5 Psychotic disorder	0.000	0.997	0.002
F12.4 Withdrawal state with delirium	0.000	0.997	0.002
F12.3 Withdrawal state	0.000	0.997	0.002
F12.2 Dependence syndrome	0.000	0.997	0.002
F12.1 Harmful use	0.000	0.997	0.002
F12.0 Acute intoxication	0.000	0.997	0.002
F13.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F13.8 Other mental and behavioural disorders	0.000	0.997	0.002
F13.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F13.6 Amnesic syndrome	0.000	0.997	0.002
F13.5 Psychotic disorder	0.000	0.997	0.002
F13.4 Withdrawal state with delirium	0.000	0.997	0.002
F13.3 Withdrawal state	0.000	0.997	0.002
F13.2 Dependence syndrome	0.000	0.997	0.002
F13.1 Harmful use	0.000	0.997	0.002
F13.0 Acute intoxication	0.000	0.997	0.002
F14.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F14.8 Other mental and behavioural disorders	0.000	0.997	0.002
F14.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F14.6 Amnesic syndrome	0.000	0.997	0.002
F14.5 Psychotic disorder	0.000	0.997	0.002
F14.4 Withdrawal state with delirium	0.000	0.997	0.002
F14.3 Withdrawal state	0.000	0.997	0.002
F14.2 Dependence syndrome	0.000	0.997	0.002
F14.1 Harmful use	0.000	0.997	0.002
F14.0 Acute intoxication	0.000	0.997	0.002
F15.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F15.8 Other mental and behavioural disorders	0.000	0.997	0.002
F15.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F15.6 Amnesic syndrome	0.000	0.997	0.002
F15.5 Psychotic disorder	0.000	0.997	0.002
F15.4 Withdrawal state with delirium	0.000	0.997	0.002
F15.3 Withdrawal state	0.000	0.997	0.002
F15.2 Dependence syndrome	0.000	0.997	0.002
F15.1 Harmful use	0.000	0.997	0.002
F15.0 Acute intoxication	0.000	0.997	0.002
F16.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F16.8 Other mental and behavioural disorders	0.000	0.997	0.002
F16.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F16.6 Amnesic syndrome	0.000	0.997	0.002
F16.5 Psychotic disorder	0.000	0.997	0.002
F16.4 Withdrawal state with delirium	0.000	0.997	0.002
F16.3 Withdrawal state	0.000	0.997	0.002
F16.2 Dependence syndrome	0.000	0.997	0.002
F16.1 Harmful use	0.000	0.997	0.002
F16.0 Acute intoxication	0.000	0.997	0.002
F18.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F18.8 Other mental and behavioural disorders	0.000	0.997	0.002
F18.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F18.6 Amnesic syndrome	0.000	0.997	0.002
F18.5 Psychotic disorder	0.000	0.997	0.002
F18.4 Withdrawal state with delirium	0.000	0.997	0.002
F18.3 Withdrawal state	0.000	0.997	0.002
F18.2 Dependence syndrome	0.000	0.997	0.002
F18.1 Harmful use	0.000	0.997	0.002
F18.0 Acute intoxication	0.000	0.997	0.002
F19.9 Unspecified mental and behavioural disorder	0.000	0.997	0.002
F19.8 Other mental and behavioural disorders	0.000	0.997	0.002
F19.7 Residual and late-onset psychotic disorder	0.000	0.997	0.002
F19.6 Amnesic syndrome	0.000	0.997	0.002
F19.5 Psychotic disorder	0.000	0.997	0.002
F19.4 Withdrawal state with delirium	0.000	0.997	0.002
F19.3 Withdrawal state	0.000	0.997	0.002
F19.2 Dependence syndrome	0.000	0.997	0.002
F19.1 Harmful use	0.000	0.997	0.002
F19.0 Acute intoxication	0.000	0.997	0.002
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.000	0.997	0.003
A00-A09 Intestinal infectious diseases	0.003	0.997	0.000
Z36 Antenatal screening	0.000	0.997	0.003
A04.9 Bacterial intestinal infection, unspecified	0.002	0.997	0.000
A04.6 Enteritis due to Yersinia enterocolitica	0.002	0.997	0.000
A04.4 Other intestinal Escherichia coli infections	0.002	0.997	0.000
A04.3 Enterohaemorrhagic Escherichia coli infection	0.002	0.997	0.000
A04.2 Enteroinvasive Escherichia coli infection	0.002	0.997	0.000
A04.1 Enterotoxigenic Escherichia coli infection	0.002	0.997	0.000
A04.0 Enteropathogenic Escherichia coli infection	0.002	0.997	0.000
F32.0 Mild depressive episode	0.000	0.997	0.002
A04.7 Enterocolitis due to Clostridium difficile	0.002	0.998	0.000
F32.1 Moderate depressive episode	0.000	0.998	0.002
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.000	0.998	0.002
L40.8 Other psoriasis	0.002	0.998	0.000
L40.4 Guttate psoriasis	0.002	0.998	0.000
L40.3 Pustulosis palmaris et plantaris	0.002	0.998	0.000
L40.2 Acrodermatitis continua	0.002	0.998	0.000
L40.1 Generalised pustular psoriasis	0.002	0.998	0.000
S82.60 Fracture of lateral malleolus (closed)	0.000	0.998	0.002
F32.8 Other depressive episodes	0.000	0.998	0.002
T42.4 Benzodiazepines	0.000	0.998	0.002
A02 Other Salmonella infections	0.002	0.998	0.000
K86.1 Other chronic pancreatitis	0.002	0.998	0.000
N81.2 Incomplete uterovaginal prolapse	0.000	0.998	0.002
J44 Other chronic obstructive pulmonary disease	0.000	0.998	0.002
K85.8 Other acute pancreatitis	0.002	0.998	0.000
K85.3 Drug-induced acute pancreatitis	0.002	0.998	0.000
K85.2 Alcohol-induced acute pancreatitis	0.002	0.998	0.000
K85.0 Idiopathic acute pancreatitis	0.002	0.998	0.000
A02.0 Salmonella gastro-enteritis	0.002	0.998	0.000
G63.2 Diabetic polyneuropathy	0.002	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.998	0.002
C71.1 Frontal lobe	0.002	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.002	0.998	0.000
K83.1 Obstruction of bile duct	0.002	0.998	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.998	0.002
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.998	0.002
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.998	0.002
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.998	0.002
A07 Other protozoal intestinal diseases	0.002	0.998	0.000
A06 Amoebiasis	0.002	0.998	0.000
A05 Other bacterial foodborne intoxications	0.002	0.998	0.000
A03 Shigellosis	0.002	0.998	0.000
A01 Typhoid and paratyphoid fevers	0.002	0.998	0.000
A00 Cholera	0.002	0.998	0.000
B91 Sequelae of poliomyelitis	0.002	0.998	0.000
J43.9 Emphysema, unspecified	0.000	0.998	0.002
M35.3 Polymyalgia rheumatica	0.002	0.998	0.000
J43 Emphysema	0.000	0.998	0.002
J40-J47 Chronic lower respiratory diseases	0.000	0.998	0.002
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.002	0.998	0.000
K83 Other diseases of biliary tract	0.002	0.998	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.000	0.998	0.002
Z43.2 Attention to ileostomy	0.000	0.998	0.002
A02.9 Salmonella infection, unspecified	0.002	0.998	0.000
A02.8 Other specified Salmonella infections	0.002	0.998	0.000
A02.2 Localised Salmonella infections	0.002	0.998	0.000
A02.1 Salmonella septicaemia	0.002	0.998	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
K83.0 Cholangitis	0.002	0.998	0.000
B90-B94 Sequelae of infectious and parasitic diseases	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.002	0.998	0.000
N39.8 Other specified disorders of urinary system	0.002	0.998	0.000
N39 Other disorders of urinary system	0.002	0.998	0.000
A00.9 Cholera, unspecified	0.002	0.998	0.000
A00.1 Cholera due to Vibrio cholerae 01, biovar el tor	0.002	0.998	0.000
A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae	0.002	0.998	0.000
A01.4 Paratyphoid fever, unspecified	0.002	0.998	0.000
A01.3 Paratyphoid fever C	0.002	0.998	0.000
A01.2 Paratyphoid fever B	0.002	0.998	0.000
A01.1 Paratyphoid fever A	0.002	0.998	0.000
A01.0 Typhoid fever	0.002	0.998	0.000
A03.9 Shigellosis, unspecified	0.002	0.998	0.000
A03.8 Other shigellosis	0.002	0.998	0.000
A03.3 Shigellosis due to Shigella sonnei	0.002	0.998	0.000
A03.2 Shigellosis due to Shigella boydii	0.002	0.998	0.000
A03.1 Shigellosis due to Shigella flexneri	0.002	0.998	0.000
A03.0 Shigellosis due to Shigella dysenteriae	0.002	0.998	0.000
A05.9 Bacterial foodborne intoxication, unspecified	0.002	0.998	0.000
A05.8 Other specified bacterial foodborne intoxications	0.002	0.998	0.000
A05.4 Foodborne Bacillus cereus intoxication	0.002	0.998	0.000
A05.3 Foodborne Vibrio parahaemolyticus intoxication	0.002	0.998	0.000
A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication	0.002	0.998	0.000
A05.1 Botulism	0.002	0.998	0.000
A05.0 Foodborne staphylococcal intoxication	0.002	0.998	0.000
A06.9 Amoebiasis, unspecified	0.002	0.998	0.000
A06.8 Amoebic infection of other sites	0.002	0.998	0.000
A06.7 Cutaneous amoebiasis	0.002	0.998	0.000
A06.6 Amoebic brain abscess	0.002	0.998	0.000
A06.5 Amoebic lung abscess	0.002	0.998	0.000
A06.4 Amoebic liver abscess	0.002	0.998	0.000
A06.3 Amoeboma of intestine	0.002	0.998	0.000
A06.2 Amoebic nondysenteric colitis	0.002	0.998	0.000
A06.1 Chronic intestinal amoebiasis	0.002	0.998	0.000
A06.0 Acute amoebic dysentery	0.002	0.998	0.000
A07.9 Protozoal intestinal disease, unspecified	0.002	0.998	0.000
A07.8 Other specified protozoal intestinal diseases	0.002	0.998	0.000
A07.3 Isosporiasis	0.002	0.998	0.000
A07.2 Cryptosporidiosis	0.002	0.998	0.000
A07.1 Giardiasis [lambliasis]	0.002	0.998	0.000
A07.0 Balantidiasis	0.002	0.998	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.000	0.998	0.002
Z43.1 Attention to gastrostomy	0.000	0.998	0.002
C92 Myeloid leukaemia	0.002	0.998	0.000
J43.8 Other emphysema	0.000	0.998	0.002
J43.2 Centrilobular emphysema	0.000	0.998	0.002
J43.1 Panlobular emphysema	0.000	0.998	0.002
J43.0 MacLeod's syndrome	0.000	0.998	0.002
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.998	0.002
B94 Sequelae of other and unspecified infectious and parasitic diseases	0.002	0.998	0.000
J41 Simple and mucopurulent chronic bronchitis	0.000	0.998	0.002
A08 Viral and other specified intestinal infections	0.002	0.998	0.000
C90.0 Multiple myeloma	0.002	0.998	0.000
K83.8 Other specified diseases of biliary tract	0.002	0.998	0.000
J40 Bronchitis, not specified as acute or chronic	0.000	0.998	0.002
R35 Polyuria	0.002	0.998	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.998	0.002
K83.9 Disease of biliary tract, unspecified	0.002	0.998	0.000
K83.5 Biliary cyst	0.002	0.998	0.000
K83.4 Spasm of sphincter of Oddi	0.002	0.998	0.000
K83.3 Fistula of bile duct	0.002	0.998	0.000
K83.2 Perforation of bile duct	0.002	0.998	0.000
B94.8 Sequelae of other specified infectious and parasitic diseases	0.002	0.998	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.998	0.002
Y84.0 Cardiac catheterisation	0.002	0.998	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
J34.3 Hypertrophy of nasal turbinates	0.000	0.998	0.002
Z43.6 Attention to other artificial openings of urinary tract	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
K56.4 Other impaction of intestine	0.002	0.998	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.998	0.001
J42 Unspecified chronic bronchitis	0.000	0.998	0.002
C83.3 Large cell (diffuse)	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
G93.3 Postviral fatigue syndrome	0.000	0.998	0.002
K00.6 Disturbances in tooth eruption	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.001	0.998	0.000
B90 Sequelae of tuberculosis	0.001	0.998	0.000
B92 Sequelae of leprosy	0.001	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
G25.8 Other specified extrapyramidal and movement disorders	0.000	0.998	0.002
K04.8 Radicular cyst	0.002	0.998	0.000
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.002	0.998	0.000
N39.2 Orthostatic proteinuria, unspecified	0.001	0.998	0.000
N39.1 Persistent proteinuria, unspecified	0.001	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.001	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.001	0.998	0.000
C92.7 Other myeloid leukaemia	0.001	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.001	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.001	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.001	0.998	0.000
C92.3 Myeloid sarcoma	0.001	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.001	0.998	0.000
G43.9 Migraine, unspecified	0.000	0.998	0.002
S82.6 Fracture of lateral malleolus	0.000	0.998	0.001
Z11.0 Special screening examination for intestinal infectious diseases	0.000	0.998	0.002
B94.9 Sequelae of unspecified infectious or parasitic disease	0.001	0.998	0.000
B94.2 Sequelae of viral hepatitis	0.001	0.998	0.000
B94.1 Sequelae of viral encephalitis	0.001	0.998	0.000
B94.0 Sequelae of trachoma	0.001	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.001	0.998	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.000	0.998	0.001
J41.1 Mucopurulent chronic bronchitis	0.000	0.998	0.001
J41.0 Simple chronic bronchitis	0.000	0.998	0.001
Z43.3 Attention to colostomy	0.000	0.998	0.001
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.001	0.998	0.000
A08.5 Other specified intestinal infections	0.001	0.998	0.000
A08.3 Other viral enteritis	0.001	0.998	0.000
A08.2 Adenoviral enteritis	0.001	0.998	0.000
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.001	0.998	0.000
A08.0 Rotaviral enteritis	0.001	0.998	0.000
J46 Status asthmaticus	0.000	0.998	0.001
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.001	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.001	0.998	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.000	0.998	0.002
K13.7 Other and unspecified lesions of oral mucosa	0.002	0.998	0.000
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions	0.001	0.998	0.000
B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases	0.001	0.998	0.000
B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms	0.001	0.998	0.000
B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases	0.001	0.998	0.000
Z43 Attention to artificial openings	0.000	0.998	0.001
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.999	0.001
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
C95 Leukaemia of unspecified cell type	0.001	0.999	0.000
C94 Other leukaemias of specified cell type	0.001	0.999	0.000
C93 Monocytic leukaemia	0.001	0.999	0.000
C88 Malignant immunoproliferative diseases	0.001	0.999	0.000
C86 Other specified types of T/NK-cell lymphoma	0.001	0.999	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.001	0.999	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.001	0.999	0.000
Chapter I Certain infectious and parasitic diseases	0.001	0.999	0.000
C83.7 Burkitt's tumour	0.001	0.999	0.000
C83.6 Undifferentiated (diffuse)	0.001	0.999	0.000
C83.5 Lymphoblastic (diffuse)	0.001	0.999	0.000
C83.4 Immunoblastic (diffuse)	0.001	0.999	0.000
C83.2 Mixed small and large cell (diffuse)	0.001	0.999	0.000
C83.1 Small cleaved cell (diffuse)	0.001	0.999	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.001	0.999	0.000
K51.9 Ulcerative colitis, unspecified	0.001	0.999	0.000
N39.4 Other specified urinary incontinence	0.001	0.999	0.000
C81 Hodgkin's disease	0.001	0.999	0.000
B90.9 Sequelae of respiratory and unspecified tuberculosis	0.001	0.999	0.000
B90.8 Sequelae of tuberculosis of other organs	0.001	0.999	0.000
B90.2 Sequelae of tuberculosis of bones and joints	0.001	0.999	0.000
B90.1 Sequelae of genito-urinary tuberculosis	0.001	0.999	0.000
B90.0 Sequelae of central nervous system tuberculosis	0.001	0.999	0.000
C71 Malignant neoplasm of brain	0.001	0.999	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.001	0.999	0.000
K86 Other diseases of pancreas	0.001	0.999	0.000
K82.9 Disease of gallbladder, unspecified	0.001	0.999	0.000
N41.1 Chronic prostatitis	0.001	0.999	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.999	0.001
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.999	0.001
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.999	0.001
T42.3 Barbiturates	0.000	0.999	0.001
T42.2 Succinimides and oxazolidinediones	0.000	0.999	0.001
T42.1 Iminostilbenes	0.000	0.999	0.001
T42.0 Hydantoin derivatives	0.000	0.999	0.001
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.001	0.999	0.000
K82 Other diseases of gallbladder	0.001	0.999	0.000
A50-A64 Infections with a predominantly sexual mode of transmission	0.001	0.999	0.000
S82.61 Fracture of lateral malleolus (open)	0.000	0.999	0.001
C91.9 Lymphoid leukaemia, unspecified	0.001	0.999	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.001	0.999	0.000
C91.7 Other lymphoid leukaemia	0.001	0.999	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.001	0.999	0.000
C91.5 Adult T-cell leukaemia	0.001	0.999	0.000
C91.4 Hairy-cell leukaemia	0.001	0.999	0.000
C91.3 Prolymphocytic leukaemia	0.001	0.999	0.000
C91.2 Subacute lymphocytic leukaemia	0.001	0.999	0.000
C91.0 Acute lymphoblastic leukaemia	0.001	0.999	0.000
K14.8 Other diseases of tongue	0.001	0.999	0.000
T39.0 Salicylates	0.000	0.999	0.001
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.001	0.999	0.000
C71.2 Temporal lobe	0.001	0.999	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.999	0.001
K00 Disorders of tooth development and eruption	0.001	0.999	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.999	0.001
C82.6 Cutaneous follicle centre lymphoma	0.001	0.999	0.000
C82.5 Diffuse follicle centre lymphoma	0.001	0.999	0.000
C82.4 Follicular lymphoma grade IIIb	0.001	0.999	0.000
C82.3 Follicular lymphoma grade IIIa	0.001	0.999	0.000
C82.2 Large cell, follicular	0.001	0.999	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.001	0.999	0.000
C82.0 Small cleaved cell, follicular	0.001	0.999	0.000
E83.1 Disorders of iron metabolism	0.001	0.999	0.000
K10.2 Inflammatory conditions of jaws	0.001	0.999	0.000
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.001	0.999	0.000
B00 Herpesviral [herpes simplex] infections	0.001	0.999	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.000	0.999	0.001
B20.9 HIV disease resulting in unspecified infectious or parasitic disease	0.001	0.999	0.000
B20.8 HIV disease resulting in other infectious and parasitic diseases	0.001	0.999	0.000
B20.7 HIV disease resulting in multiple infections	0.001	0.999	0.000
B20.6 HIV disease resulting in Pneumocystis carinii pneumonia	0.001	0.999	0.000
B20.5 HIV disease resulting in other mycoses	0.001	0.999	0.000
B20.4 HIV disease resulting in candidiasis	0.001	0.999	0.000
B20.3 HIV disease resulting in other viral infections	0.001	0.999	0.000
B20.2 HIV disease resulting in cytomegaloviral disease	0.001	0.999	0.000
B20.1 HIV disease resulting in other bacterial infections	0.001	0.999	0.000
B20.0 HIV disease resulting in mycobacterial infection	0.001	0.999	0.000
B21.9 HIV disease resulting in unspecified malignant neoplasm	0.001	0.999	0.000
B21.8 HIV disease resulting in other malignant neoplasms	0.001	0.999	0.000
B21.7 HIV disease resulting in multiple malignant neoplasms	0.001	0.999	0.000
B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
B21.2 HIV disease resulting in other types of non-Hodgkin's lymphoma	0.001	0.999	0.000
B21.1 HIV disease resulting in Burkitt's lymphoma	0.001	0.999	0.000
B21.0 HIV disease resulting in Kaposi's sarcoma	0.001	0.999	0.000
B22.7 HIV disease resulting in multiple diseases classified elsewhere	0.001	0.999	0.000
B22.2 HIV disease resulting in wasting syndrome	0.001	0.999	0.000
B22.1 HIV disease resulting in lymphoid interstitial pneumonitis	0.001	0.999	0.000
B22.0 HIV disease resulting in encephalopathy	0.001	0.999	0.000
B23.8 HIV disease resulting in other specified conditions	0.001	0.999	0.000
B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified	0.001	0.999	0.000
B23.1 HIV disease resulting in (persistent) generalised lymphadenopathy	0.001	0.999	0.000
B23.0 Acute HIV infection syndrome	0.001	0.999	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.001	0.999	0.000
G93.9 Disorder of brain, unspecified	0.000	0.999	0.001
K04.7 Periapical abscess without sinus	0.001	0.999	0.000
K35.9 Acute appendicitis, unspecified	0.001	0.999	0.000
N39.9 Disorder of urinary system, unspecified	0.001	0.999	0.000
Z43.9 Attention to unspecified artificial opening	0.000	0.999	0.001
Z43.7 Attention to artificial vagina	0.000	0.999	0.001
Z43.0 Attention to tracheostomy	0.000	0.999	0.001
S82.21 Fracture of shaft of tibia (open)	0.001	0.999	0.000
A63.0 Anogenital (venereal) warts	0.001	0.999	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.001	0.999	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.001	0.999	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.001	0.999	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.001	0.999	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.999	0.000
C84.4 Peripheral T-cell lymphoma	0.001	0.999	0.000
C84.3 Lymphoepithelioid lymphoma	0.001	0.999	0.000
C84.2 T-zone lymphoma	0.001	0.999	0.000
C84.1 Sezary's diease	0.001	0.999	0.000
C84.0 Mycosis fungoides	0.001	0.999	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.001	0.999	0.000
C85.0 Lymphosarcoma	0.001	0.999	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.999	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.999	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.999	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.999	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.999	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.999	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.999	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.001	0.999	0.000
C88.7 Other malignant immunoproliferative diseases	0.001	0.999	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.001	0.999	0.000
C88.3 Immunoproliferative small intestinal disease	0.001	0.999	0.000
C88.2 Gamma heavy chain disease	0.001	0.999	0.000
C88.1 Alpha heavy chain disease	0.001	0.999	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.001	0.999	0.000
C93.9 Monocytic leukaemia, unspecified	0.001	0.999	0.000
C93.7 Other monocytic leukaemia	0.001	0.999	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.001	0.999	0.000
C93.2 Subacute monocytic leukaemia	0.001	0.999	0.000
C93.1 Chronic monocytic leukaemia	0.001	0.999	0.000
C93.0 Acute monocytic leukaemia	0.001	0.999	0.000
C94.7 Other specified leukaemias	0.001	0.999	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.999	0.000
C94.5 Acute myelofibrosis	0.001	0.999	0.000
C94.4 Acute panmyelosis	0.001	0.999	0.000
C94.3 Mast cell leukaemia	0.001	0.999	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.999	0.000
C94.1 Chronic erythraemia	0.001	0.999	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.999	0.000
C95.9 Leukaemia, unspecified	0.001	0.999	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.999	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.999	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.001	0.999	0.000
C95.0 Acute leukaemia of unspecified cell type	0.001	0.999	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.999	0.000
C96.8 Histiocytic sarcoma	0.001	0.999	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.999	0.000
C96.3 True histiocytic lymphoma	0.001	0.999	0.000
C96.2 Malignant mast cell tumour	0.001	0.999	0.000
C96.1 Malignant histiocytosis	0.001	0.999	0.000
C96.0 Letterer-Siwe disease	0.001	0.999	0.000
I65.2 Occlusion and stenosis of carotid artery	0.000	0.999	0.001
K12.3 Oral mucositis (ulcerative)	0.001	0.999	0.000
K57.3 Diverticular disease of large intestine without perforation or abscess	0.001	0.999	0.000
K82.1 Hydrops of gallbladder	0.001	0.999	0.000
B99-B99 Other infectious diseases	0.001	0.999	0.000
B85-B89 Pediculosis, acariasis and other infestations	0.001	0.999	0.000
B65-B83 Helminthiases	0.001	0.999	0.000
B50-B64 Protozoal diseases	0.001	0.999	0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.001	0.999	0.000
A80-A89 Viral infections of the central nervous system	0.001	0.999	0.000
A75-A79 Rickettsioses	0.001	0.999	0.000
A70-A74 Other diseases caused by chlamydiae	0.001	0.999	0.000
A65-A69 Other spirochaetal diseases	0.001	0.999	0.000
A20-A28 Certain zoonotic bacterial diseases	0.001	0.999	0.000
A15-A19 Tuberculosis	0.001	0.999	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.999	0.001
K50.9 Crohn's disease, unspecified	0.000	0.999	0.001
B02 Zoster [herpes zoster]	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations